Approved Uses Otezla® (apremilast) is a prescription medicine used to treat adult patients with:

  • Plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
  • Active psoriatic arthritis.
  • Oral ulcers associated with Behçet’s Disease.

Benefits of Otezla

 
clear skin pillclear skin pill

Otezla is not a cream or injection. It’s the only pill approved to treat mild, moderate, and severe plaque psoriasis

Otezla® (apremilast) pill can help achieve clearer skin after 4 monthsOtezla® (apremilast) pill can help achieve clearer skin after 4 months

Otezla can help you achieve clearer skin after just 4 months
SEE RESULTS

Graphic representation of patient population treated with Otezla® (apremilast)Graphic representation of patient population treated with Otezla® (apremilast)

Doctor-prescribed for over 8 years, more than 700,000 people have been treated with Otezla

#1 Icon#1 Icon

#1 Prescribed Brand for adults with moderate to severe psoriasis starting a treatment that works inside the body*

clear skin pillclear skin pill

Otezla is proven to help get clearer skin on your scalp after just 4 months in people with moderate to severe plaque psoriasis
SEE SCALP DATA

ModerateModerate

Otezla works to reduce PDE4 activity. PDE4 is an enzyme that is believed to contribute to the inflammation associated with plaque psoriasis, though the exact way in which Otezla helps improve symptoms isn't completely understood

*Based on IQVIA licensed data: Jan 2018—May 2022 Longitudinal Prescription (LRx) Data and Medical Claims (Dx) Data, reflecting estimates of real-world activity. Study information maintained by Amgen. LRx Data covers retail, traditional/specialty mail order, and long-term claims. Dx data captures US physicians. Patient classified as systemic-naïve if not previously on systemic therapy for the past 12 months, had any claim for a branded systemic, and had at least one psoriasis diagnosis.

*Based on IQVIA licensed data: Jan 2018—May 2022 Longitudinal Prescription (LRx) Data and Medical Claims (Dx) Data, reflecting estimates of real-world activity. Study information maintained by Amgen. LRx Data covers retail, traditional/specialty mail order, and long-term claims. Dx data captures US physicians. Patient classified as systemic-naïve if not previously on systemic therapy for the past 12 months, had any claim for a branded systemic, and had at least one psoriasis diagnosis.

elicia white$name

“The best part of Otezla is that it works for me.”
-Elicia, Actual Otezla patient

Meet Jennifer

Jennifer’s plaque psoriasis symptoms made her self‑conscious. With Otezla, she's living life more on her own terms.

$name

Important Safety Information

You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

Otezla can cause allergic reactions, sometimes severe. Stop using Otezla and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.

Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of complications from having severe diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.

Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.

Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.

Some medicines may make Otezla less effective, and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.

The most common side effects of Otezla include diarrhea, nausea, upper respiratory tract infection, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.

Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.

Please click here for the Full Prescribing Information for Otezla.

APPROVED USES

Otezla® (apremilast) is a prescription medicine used to treat adult patients with:

  • Plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
  • Active psoriatic arthritis.
  • Oral ulcers associated with Behçet’s Disease.
Important Safety Information

You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

Otezla can cause allergic reactions, sometimes severe. Stop using Otezla and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.

Sign up for support

Information about paying for Otezla

 

You are now leaving otezla.com and going to Facebook

The content of the linked site is the sole responsibility of the site provider. Amgen Corporation does not control or endorse this third-party website.

Click "OK" to proceed or "CANCEL" to return to otezla.com.

You are now leaving otezla.com and going to Instagram

The content of the linked site is the sole responsibility of the site provider. Amgen Corporation does not control or endorse this third-party website.

Click "OK" to proceed or "CANCEL" to return to otezla.com.

You are now leaving otezla.com and going to Youtube

The content of the linked site is the sole responsibility of the site provider. Amgen Corporation does not control or endorse this third-party website.

Click "OK" to proceed or "CANCEL" to return to otezla.com.

You are now leaving otezla.com and going to Amgen.com

Are you sure you want to do this?

You are now leaving otezla.com and going to Amgen’s “Contact Us” page

Are you sure you want to do this?

You are now leaving otezla.com and going to www.fda.gov/medwatch

The content of the linked site is the sole responsibility of the site provider. Amgen Inc. does not control or endorse this third-party website.

Click "OK" to proceed or "CANCEL" to return to otezla.com.